Last reviewed · How we verify

NCT03341611

The Effect of Aging on Value Based Decision-making

Completed Last updated 22 May 2019
What this trial tests

trial testing Neuro-imaging during behavioral decision-making task in Healthy Aging in 90 participants. Completed in 30 April 2018.

Timeline
1 January 2016
Primary endpoint
30 April 2018
30 April 2018

Quick facts

Lead sponsorUniversity of Southern California
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 January 2016
Primary completion30 April 2018
Estimated completion30 April 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

18 and older, any sex, with Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose to study the effect of aging on the neural circuitry involved in valuation and value reasoning and to relate it to choice anomalies and inconsistencies. Quantifying and characterizing valuation-based decision-making deficits in older adults, and their relationship to the aging brain, can inform and facilitate intervention - both at the level of the individual and at the level of policy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Aging

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing